FindTrial
Sign In

Predictive and personalized medicine for rheumatoid arthritis through next generation genetic technology

Predictive and personalized medicine for rheumatoid arthritis through next generation genetic technology

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0000408
Enrollment
3000
Registered
2012-04-19
Start date
2011-11-10
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Hanyang University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Consecutive RA patients who visit Hanyang University Hospital for Rheumatic Diseases and give the informed consent

Exclusion criteria

Exclusion criteria: -

Design outcomes

Primary

MeasureTime frame
Discovery for rheumatoid arthritis risk gene—

Secondary

MeasureTime frame
Genetic risk score for rheumatoid arthritis—

Countries

Korea, Republic of

Contacts

Public ContactHye-Soon Lee

Hanyang University

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026